Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2012
08/02/2012WO2012064300A3 Desloratadine granules
08/02/2012WO2012061698A3 Compounds useful as modulators of trpm8
08/02/2012WO2012061418A3 Benzamides and nicotinamides as syk modulators
08/02/2012WO2012061400A3 Method for reduction of free polysaccharide in polysaccharide-protein vaccines reactions using ion-exchange matrices
08/02/2012WO2012061248A3 Novel specific hcv ns3 protease inhibitors
08/02/2012WO2012058675A3 Zinc oxide complexes
08/02/2012WO2012058581A3 Non-hormonal female contraceptive
08/02/2012WO2012058211A3 Quinazoline derivatives, compositions, and uses related thereto
08/02/2012WO2012054528A3 Chemosensory receptor ligand-based therapies
08/02/2012WO2012054446A3 Combination therapy
08/02/2012WO2012054366A3 Substituted amino-triazolyl pde10 inhibitors
08/02/2012WO2012053741A9 Nucleic acid molecules inducing rna interference, and uses thereof
08/02/2012WO2012053014A3 Method for treatment of acne using pharmaceutical compositions of clindamycin and adapalene
08/02/2012WO2012053013A3 Pharmaceutical compositions of anti-acne agents
08/02/2012WO2012053010A3 Method for treatment of acne using pharmaceutical compositions of clindamycin
08/02/2012WO2012051296A3 Purine-based triazoles
08/02/2012WO2012050922A3 Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract
08/02/2012WO2012049327A3 Pesticidal mixtures
08/02/2012WO2012048316A3 Regulators of nfat and/or store-operated calcium entry
08/02/2012WO2012047893A3 Use of rifazil and analogues thereof to treat ocular disorders
08/02/2012WO2012042197A3 Low dose pharmaceutical composition comprising zanamivir
08/02/2012WO2012037562A3 Pharmaceutical and nutraceutical compositions of abscisic acid
08/02/2012WO2012037193A3 Formulations for treatment with glucosinolate
08/02/2012WO2012031999A3 Low-dose transdermal patches with high drug release
08/02/2012WO2012030914A8 4-azolylaminoquinazoline derivatives and methods of use thereof
08/02/2012WO2012027378A3 Particles for drug delivery and other applications
08/02/2012WO2012019990A3 Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
08/02/2012WO2012019989A3 Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
08/02/2012WO2012017349A3 Topical pharmaceutical composition comprising nanonized silver sulfadiazine and chlorhexidine gluconate
08/02/2012WO2012011740A8 Method for preparing microspheres and microspheres produced thereby
08/02/2012WO2011157443A8 (11β,17α)-11-(4-(2-11C-ACETYL)PHENYL)-17,23-EPOXY- 19,24-DINORCHOLA-4,9,20-TRIEN-3-ONE
08/02/2012WO2011113802A3 Imidazopyridine and purine compounds, compositions and methods of use
08/02/2012WO2011113579A3 Fragments of the pa subunit of rna dependent rna polymerase from pandemic influenza virus a 2009 h1n1, and their use
08/02/2012WO2011107653A8 Use of levodopa, carbidopa and entacapone for treating parkinson's disease
08/02/2012WO2011100209A3 Magnetically sensitive drug carriers for treatment or targeted delivery
08/02/2012WO2011095882A8 Combination composition, comprising as active ingredient l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiency
08/02/2012WO2011070253A8 Azabicyclo[3.1.0]hex-2-yl derivatives, method for preparing same, and pharmaceutical compositions containing same
08/02/2012WO2009108392A3 Catalytic enantioselective synthesis of flavanones and chromanes
08/02/2012US20120198576 Methods for making embryonic cells, embryos, and animals sensitized to stress
08/02/2012US20120197221 Transepidermal drug delivery system containing rivastigmine
08/02/2012US20120197027 Quinazoline Derivatives as Angiogenesis Inhibitors
08/02/2012US20120196939 Therapeutic Compounds
08/02/2012US20120196938 Beta 2 Adrenergic Receptor Agonists Such As Terbutaline for Use in the Treatment of Nocturnal Hypoglycemia
08/02/2012US20120196937 Treatment of ophthalmic disorders using urea
08/02/2012US20120196936 Composition Comprising S-Allyl-L-Cysteine as Active Ingredient for Preventing or Treating Gastrointestinal Disorders
08/02/2012US20120196935 Methods for detecting autodigestion
08/02/2012US20120196934 Compositions comprising a fatty acid oil mixture comprising epa and dha in free acid form and a surfactant, and methods and uses thereof
08/02/2012US20120196933 Mexiletine prodrugs
08/02/2012US20120196932 Use of Medium Chain Triglycerides for the Treatment and Prevention of Alzheimer's Disease and Other Diseases Resulting from Reduced Neuronal Metabolism
08/02/2012US20120196931 Treatment for Multiple Sclerosis
08/02/2012US20120196930 Topical formulation for diabetic foot ulcers
08/02/2012US20120196929 Use of Rosmarinic Acid and the Derivaties Thereof to Treat Ciguatera
08/02/2012US20120196928 Red yeast rice extract high in monacolin k content
08/02/2012US20120196927 Prophylactic and/or therapeutic agent for metabolic syndrome
08/02/2012US20120196926 Benzopyran compounds as melanogenesis modifiers and uses thereof
08/02/2012US20120196925 Therapeutic and Diagnostic Molecules
08/02/2012US20120196923 Polymers for delivering a substance into a cell
08/02/2012US20120196922 Znf206: a novel regulator of embryonic stem cell self-renewal and pluripotency
08/02/2012US20120196921 Modulation of sglt-2 expression
08/02/2012US20120196920 Antisense oligonucleotides against acetylcholinesterase for treating inflammatory diseases
08/02/2012US20120196919 Ex-vivo treatment of immunological disorders with pkc-theta inhibitors
08/02/2012US20120196918 PREVENTING ISLET INFLAMMATION AND DYSFUNCTION AND MAINTAINING PROPER GLUCOSE LEVELS BY CONTROLLING eIF5A AND ITS HYPUSINATION
08/02/2012US20120196917 Antidepressant Oral Liquid Compositions
08/02/2012US20120196916 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
08/02/2012US20120196915 Antitumor 1,2-Diphenylpyrrole Compounds and their Preparation Process
08/02/2012US20120196914 Ketorolac tromethamine compositions for treating or preventing ocular pain
08/02/2012US20120196913 Ketorolac tromethamine compositions for treating or preventing ocular pain
08/02/2012US20120196911 Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same
08/02/2012US20120196910 Use of azabicyclo hexane derivatives
08/02/2012US20120196909 Deferacirox dispersible tablets
08/02/2012US20120196908 Benzyl aralkyl ether compounds, method for preparing same, intermediate compounds, use of said compounds, method for treatment and/or prevention, pharmaceutical composition and medicament containing same
08/02/2012US20120196907 Diazonamide Analogs
08/02/2012US20120196906 Substituted Imidazole Derivatives, Compositions, and Methods of Use as PTPase Inhibitors
08/02/2012US20120196905 Synthetic compounds and methods to decrease nicotine self-administration
08/02/2012US20120196904 Nitrocatechol derivatives as comt inhibitors
08/02/2012US20120196903 2-aminooxazolines as taar1 ligands
08/02/2012US20120196902 Sulfoximines as kinase inhibitors
08/02/2012US20120196901 Tertiary amide orexin receptor antagonists
08/02/2012US20120196900 Pyridine non-classical cannabinoid compounds and related methods of use
08/02/2012US20120196899 Methods and products for treating inflammation
08/02/2012US20120196898 Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation
08/02/2012US20120196897 New compounds
08/02/2012US20120196896 Treatment for Oxidative Stress and/or Hypertension
08/02/2012US20120196895 Novel forms of eperisone
08/02/2012US20120196894 Novel trpa1 antagonists
08/02/2012US20120196893 Composition, method, system and kit for optical electrophysiology
08/02/2012US20120196892 Novel caspase-2 inhibitors
08/02/2012US20120196890 4-substituted azaadamantane derivatives and methods of use thereof
08/02/2012US20120196889 Catecholamine derivatives and prodrugs thereof
08/02/2012US20120196888 Process for preparing oxymorphone, naltrexone, and buprenorphine
08/02/2012US20120196887 Methods and compositions for improved rifamycin therapies
08/02/2012US20120196886 Combination
08/02/2012US20120196885 New histone deacetylase inhibitors based simultaneously on trisubstituted 1h-pyrroles and aromatic and heteroaromatic spacers
08/02/2012US20120196884 Urea substituted sulphonamide derivatives
08/02/2012US20120196883 Selective calcium channel antagonists
08/02/2012US20120196882 Compounds that treat malaria and prevent malaria transmission
08/02/2012US20120196881 Treatment Of Pulmonary Hypertension With Carbonic Anhydrase Inhibitors
08/02/2012US20120196880 Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
08/02/2012US20120196879 Pharmaceutical Combination of MEK Inhibitor and B-RAF Inhibitors
08/02/2012US20120196878 Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders
1 ... 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 ... 7860